References
[1] . Freeman, R. V. & Otto, C. M. Spectrum of Calcific Aortic Valve Disease. Circulation 111, 3316–3326 (2005).
[2] . Foroutan, F. et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ i5065 (2016) doi:10.1136/bmj.i5065.
[3] . Lindroos, M., Kupari, M., Heikkilä, J. & Tilvis, R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220–1225 (1993).
[4] . Guerbaii, R.-A. et al. Asymptomatic aortic stenosis: An assessment of patients’ and of their general practitioners’ knowledge, after an indexed specialized assessment in community practice. PLOS ONE 12, e0178932 (2017).
[5] . Thoenes, M. et al. Patient screening for early detection of aortic stenosis (AS)—review of current practice and future perspectives. J. Thorac. Dis. 10, 5584 (2018).
[6] . Aortic Stenosis Overview. www.heart.org https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/heart-valve-problems-and-causes/problem-aortic-valve-stenosis.
[7] . Overview: Heart valve diseases. in InformedHealth.org [Internet] (Institute for Quality and Efficiency in Health Care (IQWiG), 2019).
[8] . Meredith Am, I. T. et al. Transcatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve System. J. Am. Coll. Cardiol. 64, 1339–1348 (2014).
[9] . Redaelli, A. & Cooper-White, J. Bioengineering of the heart. APL Bioeng. 4, 010402 (2020).
[10] . Hadji, F. et al. Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1. Circulation 134, 1848–1862 (2016).
[11] . Pathogenesis of Calcific Aortic Valve Disease | Arteriosclerosis, Thrombosis, and Vascular Biology. https://www.ahajournals.org/doi/full/10.1161/01.ATV.0000227513.13697.ac.
[12] . Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).
[13] . S, á M. P. B. O. et al. Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement. JACC Cardiovasc. Interv. 14, 211–220 (2021).
[14] . Komosa, A. et al. Transcatheter Aortic Valve Replacement Is Associated with Less Oxidative Stress and Faster Recovery of Antioxidant Capacity than Surgical Aortic Valve Replacement. J. Clin. Med. 8, 1364 (2019).
[15] . Smith, C. R. et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N. Engl. J. Med. 364, 2187–2198 (2011).
[16] . Nishimura, R. A. et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129, e521-643 (2014).
[17] . Vahanian, A. VALVE DISEASE: Balloon valvuloplasty. Heart 85, 223–228 (2001).
[18] . Phan, K., Zhou, J. J., Niranjan, N., Di Eusanio, M. & Yan, T. D. Minimally invasive reoperative aortic valve replacement: a systematic review and meta-analysis. Ann. Cardiothorac. Surg. 4, 15–25 (2015).
[19] . Lee, J. W., Lee, S. K., Choo, S. J., Song, H. & Song, M. G. Routine minimally invasive aortic valve procedures. Cardiovasc. Surg. Lond. Engl. 8, 484–490 (2000).
[20] . Christiansen, S. et al. Minimally-invasive versus conventional aortic valve replacement--perioperative course and mid-term results. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 16, 647–652 (1999).
[21] . Goel, K. & Holmes, D. R. J. Transcatheter Aortic Valve Replacement: OPTIMIZING OUTCOMES FOR HEALTHY RECOVERY. J. Cardiopulm. Rehabil. Prev. 38, 1 (2018).
[22] . Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement | Valvular Heart Disease | JAMA | JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/2190986.
[23] . Tarro Genta, F. et al. Cardiac rehabilitation after transcatheter aortic valve implantation compared to patients after valve replacement. J. Cardiovasc. Med. 18, 114 (2017).
[24] . Shah, K. K. et al. Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study. Heart Lung Circ. 30, 1918–1928 (2021).
[25] . Muneretto, C. et al. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in “real-world” patients with aortic stenosis and intermediate- to high-risk profile. J. Thorac. Cardiovasc. Surg. 150, 1570–1579 (2015).
[26] . Mendelson, K. & Schoen, F. J. Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges. Ann. Biomed. Eng. 34, 1799–1819 (2006).
[27] . Brown, J. M. et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 137, 82–90 (2009).
[28] . Al-Adhami, A. & Al-Attar, N. Recent advances in aortic valve replacement for aortic stenosis. F1000Research 5, F1000 Faculty Rev (2016).
[29] . Kamo, Y. et al. A study on the prevalence, distribution and related factors of heart valve calcification using coronary CT angiography. IJC Heart Vasc. 29, 100571 (2020).
[30] . Iung, B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).